Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial

Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial

Abstract Background Delirium is highly problematic in palliative care (PC). Preliminary data indicate a potential role for melatonin to prevent delirium, but no randomized controlled trials (RCTs) are reported in PC. Methods Patients aged ≥18 years, with advanced cancer, admitted to an inpatient Pal...

Full description

Bibliographic Details
Main Authors: Peter G. Lawlor, Marie T. McNamara-Kilian, Alistair R. MacDonald, Franco Momoli, Sallyanne Tierney, Nathalie Lacaze-Masmonteil, Monidipa Dasgupta, Meera Agar, Jose L. Pereira, David C. Currow, Shirley H. Bush
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Palliative Care
Subjects:
Melatonin
Delirium
Advanced cancer
Feasibility study
Randomized controlled trial
Sleep
Online Access:http://link.springer.com/article/10.1186/s12904-020-00669-z

Internet

http://link.springer.com/article/10.1186/s12904-020-00669-z

Similar Items